EMEA-000932-PIP01-10-M02
Key facts
| Active substance |
Modified allergen extract of birch pollen
|
| Therapeutic area |
Pneumology-allergology
|
| Decision number |
P/0075/2022
|
| PIP number |
EMEA-000932-PIP01-10-M02
|
| Pharmaceutical form(s) |
Suspension for injection
|
| Condition(s) / indication(s) |
Treatment of allergic rhinitis / rhino-conjunctivitis
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
ROXALL Medizin GmbH
+49 (0)408972520 |
| Decision type |
RPM: decision refers to a refusal on the application for modification of an agreed PIP
|